bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2013.
Asia
Europe, Middle East, Africa
North America
Business Review for the Year Ended December 31, 2013
22 January, 2014
bioMérieux Finalizes Acquisition of the U.S. Company BioFire, Specialized in Molecular Biology
16 January, 2014
With this acquisition, bioMérieux consolidates its position as a major player in infectious disease diagnostics and strengthens its presence in the United States.
EMSL Makes the Decision to Implement the bioMérieux VITEK® MS
11 December, 2013
VITEK® MS MALDI-TOF system reduces the time to detect microbial contaminants from days to minutes, adding a never-before possible level of safety in the production of many consumer goods.
bioMérieux is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories
05 December, 2013
bioMérieux, a world leader in the field of in vitro diagnostics, has announced that it is moving a new step forward to its comprehensive automation solution dedicated for reference or centralized molecular biology laboratories.
2013 Holiday Schedule
18 November, 2013
Please be advised of the updated 2013 holiday shipping schedule as we enter the Thanksgiving and Christmas seasons.
bioMérieux Makes a Significant Acquisition in Molecular Biology in the U.S.
03 September, 2013
With the acquisition of BioFire, bioMérieux consolidates its position as a major player in infectious disease diagnostics.
bioMérieux - First-Half 2013 Results
03 September, 2013
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 30 to approve the consolidated financial statements for the six months ended June 30, 2013.
bioMérieux Announces U.S. FDA Clearance for VITEK MS, a Revolutionary Technology Which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics
21 August, 2013
New Technology made possible by a Nobel Prize Winning discovery holds the promise to improve clinical decision-making for infectious diseases.
bioMérieux - First-Half 2013 Business Review
18 July, 2013
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2013.
bioMérieux Partners with Ultimate Labs to Bring Unprecedented Speed to Pathogen Identification for Food, Drug, and Cosmetic Manufacturers
08 July, 2013
VITEK® MS innovative system reduces the time to detect microbial contaminants from days to minutes, adding a never-before possible level of safety in the production of many consumer goods.